Alzheimer’s disease (AD) is twice as common in women than in men. The issue of menopause and menopausal hormone therapy has garnered quite a lot of attention over the last 10-20 years in particular.1,2 Does menopausal hormone therapy (MHT) increase risk of AD or decrease risk in some and not others based on other factors? A recent observational study published in June 2023, triggered the conversation anew.3
Using Danish health registries, the researchers investigated the associations of hormone therapy (HT) with dementia later in life and found an increased risk of dementia with either short-term or long-term use of HT.










0 Comments